Runx2 is a relevant biomarker, because medications such as allopurinol reduce osteoblast apoptosis, increase their viability, and reduce the risk of vascular calcification by decreasing Runx2 in animal models of hyperuricemia [31,32]. The gene discussed is RUNX2; the disease is hyperuricemia.